Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?

Affiliations

• ¹ Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France - [email protected].
• ² Department of Urology, North Hospital, Aix-Marseille University, Marseille, France - [email protected].
• ³ APHM, Marseille, France - [email protected].
• ⁴ Department of Urology, La Conception Hospital, Aix-Marseille University, Marseille, France - [email protected].
• ⁵ Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain - [email protected].
• ⁶ Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.
• ⁷ Department of Urology, Jules Bordet Institute, University of Brussels, Brussels, Belgium.
• ⁸ Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
• ⁹ Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Pesaro-Urbino, Italy.
• ¹⁰ Department of Urology, North Hospital, Aix-Marseille University, Marseille, France.
• ¹¹ Department of Urology, La Conception Hospital, Aix-Marseille University, Marseille, France.
• ¹² Department of Urology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
• ¹³ Division of Urology, University Hospital of Geneva, Geneva, Switzerland.
• ¹⁴ Department of Urology, Brest University Hospital Center, Hôpital Cavale Blanche, Brest, France.
• ¹⁵ Department of Urology, CNRS, TIMC, Grenoble INP, Grenoble Alpes University Hospital, Université Grenoble Alpes, Grenoble, France.
• ¹⁶ Department of Urology, St. Antonius Hospital, Utrecht, the Netherlands.